Sagittarius Life Science (ROCO:3205) Cyclically Adjusted FCF per Share: NT$-0.40 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:3205 Sagittarius Life Science Corp ROCO:3205
48 GF Score
Price NT$50.00
GF Value NT$17.83
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sagittarius Life Science Cyclically Adjusted FCF per Share?

Sagittarius Life Science ROCO:3205 48 Cyclically Adjusted FCF per Share is NT$-0.40 as of Dec. 2025. GuruFocus rates ROCO:3205 with a GF Score™ of 48/100 and a GF Value™ of NT$17.83 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sagittarius Life Science's adjusted free cash flow per share for the three months ended in Dec. 2025 was NT$-0.315. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$-0.40 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Sagittarius Life Science's average Cyclically Adjusted FCF Growth Rate was -158.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sagittarius Life Science was 24.30% per year. The lowest was -11.20% per year. And the median was 15.20% per year.

As of today (2026-07-27), Sagittarius Life Science's current stock price is NT$50.00. Sagittarius Life Science's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2025 was NT$-0.40. Sagittarius Life Science's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sagittarius Life Science was 133.95. The lowest was 22.07. And the median was 49.38.


Sagittarius Life Science  (ROCO:3205) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sagittarius Life Science was 133.95. The lowest was 22.07. And the median was 49.38.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sagittarius Life Science Cyclically Adjusted FCF per Share Related Terms


Sagittarius Life Science Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Sagittarius Life Science's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagittarius Life Science Cyclically Adjusted FCF per Share Chart

Sagittarius Life Science Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.97 0.73 1.07 0.68 -0.40

Sagittarius Life Science Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.92 0.97 -0.16 -0.40

ROCO:3205 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Sagittarius Life Science's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sagittarius Life Science Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sagittarius Life Science's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sagittarius Life Science's Cyclically Adjusted Price-to-FCF falls into.


ROCO:3205
48GF Score
Sagittarius Life Science Corp ROCO:3205
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sagittarius Life Science Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sagittarius Life Science's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.315/324.0540*324.0540
=-0.315

Current CPI (Dec. 2025) = 324.0540.

Sagittarius Life Science Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -4.847 238.132 -6.596
201606 9.997 241.018 13.441
201609 4.800 241.428 6.443
201612 1.071 241.432 1.438
201703 0.543 243.801 0.722
201706 -1.970 244.955 -2.606
201709 0.342 246.819 0.449
201712 0.267 246.524 0.351
201803 -2.072 249.554 -2.691
201806 0.316 251.989 0.406
201809 0.400 252.439 0.513
201812 -0.446 251.233 -0.575
201903 -1.179 254.202 -1.503
201906 -0.413 256.143 -0.522
201909 -0.577 256.759 -0.728
201912 -1.474 256.974 -1.859
202003 -1.451 258.115 -1.822
202006 -0.136 257.797 -0.171
202009 -0.582 260.280 -0.725
202012 -0.076 260.474 -0.095
202103 -0.956 264.877 -1.170
202106 -0.617 271.696 -0.736
202109 -0.660 274.310 -0.780
202112 1.084 278.802 1.260
202203 -1.393 287.504 -1.570
202206 -0.511 296.311 -0.559
202209 -0.690 296.808 -0.753
202212 0.945 296.797 1.032
202303 -1.805 301.836 -1.938
202306 0.067 305.109 0.071
202309 0.147 307.789 0.155
202312 -0.602 306.746 -0.636
202403 -0.584 312.332 -0.606
202406 -0.081 314.175 -0.084
202409 -0.491 315.301 -0.505
202412 -0.326 315.605 -0.335
202503 -0.237 319.799 -0.240
202506 -0.157 322.561 -0.158
202509 0.001 324.800 0.001
202512 -0.315 324.054 -0.315

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$-0.40 mean?
Sagittarius Life Science (ROCO:3205) has a Cyclically Adjusted FCF per Share of NT$-0.40 as of Dec. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sagittarius Life Science and its competitors.
Is Sagittarius Life Science's Cyclically Adjusted FCF per Share too high?
Sagittarius Life Science's current Cyclically Adjusted FCF per Share is NT$-0.40. Overall, Sagittarius Life Science has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sagittarius Life Science's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Sagittarius Life Science's Cyclically Adjusted FCF per Share of NT$-0.40 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sagittarius Life Science and its competitors. Sagittarius Life Science's current Cyclically Adjusted FCF per Share is NT$-0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sagittarius Life Science stock overvalued right now?
Based on GuruFocus' analysis, Sagittarius Life Science (ROCO:3205) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$17.83, compared to a current price of NT$50.00 — trading 180.4% above its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$-0.40. Sagittarius Life Science's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Sagittarius Life Science (ROCO:3205), the current Cyclically Adjusted FCF per Share is NT$-0.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sagittarius Life Science (ROCO:3205) Overvalued in 2026?

Based on GuruFocus' analysis, Sagittarius Life Science stock appears to be overvalued. The current stock price of NT$50.00 is trading 180.4% above its estimated GF Value™ of NT$17.83. GuruFocus considers Sagittarius Life Science to be Significantly Overvalued.

Key valuation signals for ROCO:3205:

  • Cyclically Adjusted FCF per Share: NT$-0.40
  • GF Value™: NT$17.83 vs. price of NT$50.00 (180.4% above fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the ROCO:3205 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sagittarius Life Science Business Description

Address No. 3, Park Street, 10-6th Floor, Nangang District, Taipei, TWN
Sagittarius Life Science Corp is a Taiwan-based company engaged in the biotechnology and pharmaceutical sectors. The segment includes: Food and Others, with the majority of revenue from Food.
48GF Score

Get the complete analysis for ROCO:3205

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.00
Price
NT$17.83
GF Value